Thermo Fisher Scientific has unveiled its latest product, the Invitrogen™ UltraComp eBeads™ Spectral Unmixing Beads, designed to significantly enhance accuracy in both spectral and conventional flow cytometry. These innovative beads facilitate the precise separation of overlapping fluorescent signals, enabling researchers to quickly identify diverse cell types, track rare populations, and maintain consistent experimental performance.
The advancement comes at a critical time for researchers utilizing flow cytometry to delve deeper into cellular phenotypes and functions, which are essential for understanding diseases and developing targeted therapies. Current flow cytometry solutions often suffer from issues like false positives, negatives, and background noise, which can obscure analysis. UltraComp eBeads mimic real cells, minimizing autofluorescence and improving signal clarity, thus yielding more reliable results.
With the introduction of this next-generation solution, Thermo Fisher sets a new benchmark in compensation bead performance, supporting a wide array of species, including mouse, rat, hamster, rabbit, and recombinant human antibodies. Trisha Dowling, Vice President/General Manager of Flow and Imaging Technologies, emphasized the importance of this launch, stating that it empowers scientists with advanced tools that enhance data accuracy and confidence in detecting and quantifying cell populations. The product is tailored for immunologists and immuno-oncologists across academic, pharmaceutical, and biotechnology sectors, as well as flow cytometry core facilities.
